5- (2-{ [6- (2, 2-difluoro-2-phenylethoxy) hexyl] amino}-l-hydroxyethyl) - 8-hydroxyquin olin-2 (1H)-one and its use in the treatment of pulmonary diseases

Details for Australian Patent Application No. 2010214855 (hide)

Owner Almirall, S.A.

Inventors Ruf, Thorsten; Massana Montejo, Eric

Agent Davies Collison Cave

Pub. Number AU-A-2010214855

PCT Pub. Number WO2010/094484

Priority 09382021.5 18.02.09 EP

Filing date 18 February 2010

Wipo publication date 26 August 2010

International Classifications

C07D 215/26 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/4704 (2006.01) - 2-Quinolinones, e.g. carbostyril

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

Event Publications

21 July 2011 PCT application entered the National Phase

  PCT publication WO2010/094484 Priority application(s): WO2010/094484

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010214861-Method for removing nitrogen

2010214854-5- (2-{ [6- (2, 2-difluoro-2-phenylethoxy) hexyl] amino} -1-hydroxyethyl) - 8-hydroxyquinolin-2 (IH)-one for the treatment of lung function